Three abstracts accepted for presentation, including one rapid oral abstract sessionPresentations to highlight ongoing clinical and translational ...
The Society for Immunotherapy of Cancer (SITC) received an incredible number of abstract submissions in 2025, more than 1,300, including many clinical based Late-breaking Abstracts. SITC is proud to ...
Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...
Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced a ...
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, ...
FastWave Medical presented new first-in-human (FIH) and pre-clinical data for its Sola™ coronary laser intravascular lithotripsy (L-IVL) system at TCT 2025 (Transcatheter Cardiovascular Therapeutics), ...
The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...
SAN FRANCISCO, Feb. 11, 2025 /PRNewswire/ -- The vast majority of clinical data abstractors believe AI would save them time, effort and cost, but concerns about data quality without human oversight ...
Leading healthcare data abstraction company evolves brand to better represent comprehensive clinical registry expertise across all medical specialties. While we built our reputation on exceptional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback